DA Berry

990 total citations
7 papers, 643 citations indexed

About

DA Berry is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, DA Berry has authored 7 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in DA Berry's work include Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (3 papers) and Statistical Methods in Clinical Trials (2 papers). DA Berry is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (3 papers) and Statistical Methods in Clinical Trials (2 papers). DA Berry collaborates with scholars based in United States. DA Berry's co-authors include Kelloff Gj, NM Hylton, L. Esserman, LA Carey, EP Winer, George Somlo, Deborah Collyar, Bhupender Singh, Mehra Golshan and C. Cirrincione and has published in prestigious journals such as Cancer Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

DA Berry

7 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DA Berry United States	5	303	215	208	110	99	7	643
NM Hylton United States	5	218 0.7×	194 0.9×	117 0.6×	90 0.8×	68 0.7×	9	519
Mirat Shah United States	9	137 0.5×	136 0.6×	263 1.3×	107 1.0×	155 1.6×	18	549
D. A. Berry United States	12	261 0.9×	73 0.3×	307 1.5×	105 1.0×	51 0.5×	27	695
Martin Jenkins United Kingdom	16	104 0.3×	192 0.9×	150 0.7×	207 1.9×	409 4.1×	54	956
Jianchang Lin United States	18	119 0.4×	276 1.3×	395 1.9×	293 2.7×	359 3.6×	84	1.0k
M N Chang United States	13	133 0.4×	140 0.7×	263 1.3×	268 2.4×	67 0.7×	20	951
Aracelis Z. Torres United States	14	162 0.5×	87 0.4×	510 2.5×	91 0.8×	388 3.9×	34	826
Tatiana M. Prowell United States	12	464 1.5×	77 0.4×	564 2.7×	218 2.0×	414 4.2×	24	1.0k
G. Bastert Germany	17	339 1.1×	98 0.5×	494 2.4×	161 1.5×	80 0.8×	94	1.2k

Countries citing papers authored by DA Berry

Since Specialization

Citations

This map shows the geographic impact of DA Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Berry more than expected).

Fields of papers citing papers by DA Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DA Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Berry. The network helps show where DA Berry may publish in the future.

Co-authorship network of co-authors of DA Berry

This figure shows the co-authorship network connecting the top 25 collaborators of DA Berry. A scholar is included among the top collaborators of DA Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DA Berry. DA Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Tanioka, Maki, Chuanwen Fan, LA Carey, et al.. (2017). Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer. Cancer Research. 77(4_Supplement). S3–5. 1 indexed citations

Hyslop, Terry, et al.. (2017). Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance). Cancer Research. 77(4_Supplement). PD1–3. 1 indexed citations

Berry, DA, Bhupender Singh, C. Cirrincione, et al.. (2016). Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance). Cancer Research. 76(4_Supplement). S2–5. 51 indexed citations

Slosberg, Eric D., Susan Snodgrass, Claudia Lebedinsky, et al.. (2015). The Signature Program: Bringing the Protocol to the Patient. Clinical Pharmacology & Therapeutics. 98(2). 124–126. 23 indexed citations

Berry, DA. (2015). Emerging innovations in clinical trial design. Clinical Pharmacology & Therapeutics. 99(1). 82–91. 32 indexed citations

Berry, DA, Bhupender Singh, Constance Cirrincione, et al.. (2013). Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance). Cancer Research. 73(24_Supplement). S5–1. 39 indexed citations

Gj, Kelloff, et al.. (2009). I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy. Clinical Pharmacology & Therapeutics. 86(1). 97–100. 496 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact